Latest topics page 22
Topics ordered by most recent activity across all 71 subcategories.
1,535 topics · page 22 of 52
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Coming back to: Training through a dose escalation week
On the subject in the title: Training through a dose escalation week Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a method is not a measurement.…
|
+68 | 74 | 46k | 4mo |
|
Follow-up: Evidence quality in the secretagogue literature: an honest assessment
On the subject in the title: Evidence quality in the secretagogue literature: an honest assessment Working notes rather than a conclusion. Comparing PIONEER 6 ( N Engl J Med , 2019) with LEADER ( N Engl J Med…
|
+20 | 24 | 18k | 4mo |
|
Grapefruit: why this class is not the class that cares
Grapefruit: why this class is not the class that cares Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
|
+126 | 139 | 4k | 4mo |
|
Reading U-100 graduations, with a conversion table — one year on
Reading U-100 graduations, with a conversion table — one year on Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have…
|
+3 | 7 | 662 | 4mo |
|
Follow-up: State-level differences that actually matter
State-level differences that actually matter — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
|
+90 | 96 | 4.1k | 4mo |
|
Preprint servers and what screening they do — the long version
On the subject in the title: Preprint servers and what screening they do — the long version Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before…
|
+7 | 11 | 26k | 4mo |
|
Coming back to: Why most self-reports here are not experiments, and that is fine
The question in the title: Why most self-reports here are not experiments, and that is fine I will give what I have already checked below so nobody repeats it. Comparing LEADER ( N Engl J Med , 2016) with…
|
+56 | 62 | 11k | 4mo |
|
Revisiting: Drawing up with one needle and injecting with another
Revisiting: Drawing up with one needle and injecting with another Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have…
|
+76 | 83 | 1.1k | 4mo |
|
Half-life, steady state, and accumulation worked through — a second dataset
Half-life, steady state, and accumulation worked through — a second dataset — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it…
|
+110 | 126 | 14k | 4mo |
|
Coming back to: Which fields on a certificate actually matter, ranked
Which fields on a certificate actually matter, ranked I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first three…
|
2 | 15k | 4mo | |
|
What a documentation review can and cannot tell you — a second dataset
The question in the title: What a documentation review can and cannot tell you — a second dataset I will give what I have already checked below so nobody repeats it. I would like to talk about documentation…
|
4 | 170 | 4mo | |
|
Injection volume, overload, and peak distortion — one year on
Injection volume, overload, and peak distortion — one year on Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an analytical one. I have…
|
+4 | 8 | 1.2k | 4mo |
|
[2026 update] Hello from a laboratory that does not do peptides
Hello from a laboratory that does not do peptides Writing it up because I had to work it out twice and would rather nobody else did. Lower-stakes topic, but the sourcing rule still applies if anyone makes a…
|
2 | 49k | 4mo | |
|
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like
On the subject in the title: Semaglutide in people without diabetes: what the evidence base looks like Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before…
|
+41 | 46 | 1.2k | 4mo |
|
Second pass at: How to ask a question when you cannot say why you are asking it
Second pass at: How to ask a question when you cannot say why you are asking it — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have tried to…
|
+73 | 81 | 16k | 4mo |
|
Pharmacy supply in the UK and the questions you will be asked
On the subject in the title: Pharmacy supply in the UK and the questions you will be asked Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what…
|
+95 | 105 | 1.3k | 4mo |
|
Labelling requirements for research chemicals
Labelling requirements for research chemicals — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked for.…
|
+5 | 9 | 45k | 4mo |
|
Which panel is worth repeating and which is worth ignoring — a second dataset
Asking directly, because I could not find a straight answer: Which panel is worth repeating and which is worth ignoring — a second dataset General question, not a request for advice about my own care — I know…
|
+108 | 117 | 46k | 4mo |
|
Liver enzymes drifting down and what that usually means
Liver enzymes drifting down and what that usually means — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this…
|
+66 | 72 | 12k | 4mo |
|
[2026 update] Publication patterns in the BPC-157 literature, examined
Publication patterns in the BPC-157 literature, examined Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURMOUNT-OSA ( N Engl J Med , 2024). Please read it…
|
+15 | 19 | 11k | 4mo |
|
Second pass at: Submitting a sample: the process end to end
Second pass at: Submitting a sample: the process end to end Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better…
|
+12 | 16 | 41k | 4mo |
|
An ABAB design with a data table and honest limitations — a second dataset
On the subject in the title: An ABAB design with a data table and honest limitations — a second dataset Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before…
|
+106 | 118 | 25k | 4mo |
|
Follow-up: Request: a per-category review queue
On the subject in the title: Request: a per-category review queue Working notes rather than a conclusion. Nominating something for promotion into the documentation commons. The topic in question keeps being…
|
2 | 14k | 4mo | |
|
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still hold?
Asking directly, because I could not find a straight answer: Air bubbles in a subcutaneous injection: the honest risk assessment — does this still hold? Reporting something rather than asking about it, in…
|
+21 | 30 | 20k | 4mo |
|
Preprint servers and what screening they do
Preprint servers and what screening they do — setting out what I have, and where I think it stops being reliable. I have seen FLOW ( N Engl J Med , 2024) cited in support of a claim I do not think it…
|
+95 | 106 | 5.6k | 4mo |
|
Second pass at: Counter-ion content and its effect on measured mass
Second pass at: Counter-ion content and its effect on measured mass Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like…
|
4 | 16k | 4mo | |
|
Measurement error in home scales, with a worked standard deviation
Measurement error in home scales, with a worked standard deviation Writing it up because I had to work it out twice and would rather nobody else did. Comparing SURPASS-4 ( Lancet , 2021) with STEP 1 ( N Engl…
|
+26 | 31 | 4.3k | 4mo |
|
Run-in periods and the population they select — the long version
Run-in periods and the population they select — the long version Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SUSTAIN 6 ( N Engl J Med , 2016). Please read…
|
2 | 8.9k | 4mo | |
|
Second pass at: Identical chromatograms across two different lots
Posting this under the heading it deserves: Second pass at: Identical chromatograms across two different lots Everything below is what sits behind that. A logistics question, since the answers here are…
|
+81 | 93 | 13k | 4mo |
|
Second pass at: Choosing a concentration on purpose rather than by accident
Second pass at: Choosing a concentration on purpose rather than by accident Writing it up because I had to work it out twice and would rather nobody else did. A question about technique rather than about…
|
+49 | 54 | 6k | 4mo |